Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-24

Clinical Trial Update: Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis

View source ↗

Summary

This update describes a single-patient expanded-access protocol for Tradipitant in gastroparesis (including diabetic gastroparesis), sponsored by Vanda Pharmace…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tradipitant (tradipitant)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Gastroparesis, Diabetic Gastroparesis | Status: AVAILABLE